Area of research
Genetics · Hematology
Research interest
Research focused on Azacitidine and Plerixafor, with related work in Incidence (geometry), Disease, Alemtuzumab. Notable publications include 'A trial of unrelated donor marrow transplantation for children with severe sickle cell disease', 'Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance', and 'Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and...'.
G‐ <scp>CSF</scp> for Mobilizing <scp> CD34 <sup>+</sup> </scp> Cells in Individuals With <scp>SCD</scp> : A Word of Caution
Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium
Long‐term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial
Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease